ArticleScientific reports2025
Cadaveric evidence on lymph node counts and grossing accuracy in pelvic lymph node dissection for prostate cancer staging.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Pelvic lymph node dissection (PLND) remains the most accurate method for staging prostate cancer, yet the adequacy of nodal yield and the absence of standardized specimen processing remain unresolved. This cadaveric study aimed to establish histologically verified benchmarks for lymph node number, size, and detectability. Super-extended PLND was performed in 13 male soft-embalmed cadavers prepared with arterial silicone injection. Specimens were grossed under stereomicroscopy, and all tissue was submitted for histology. A total of 641 lymph nodes were identified, with a median of 46 nodes per cadaver (range 17-92). All extended dissections exceeded the commonly proposed minimum threshold of 10 nodes. The median lymph node size was 4.1 mm, but only 58.1% were detected grossly, while 41.9% were identified exclusively by histology. Detection was strongly size-dependent, with logistic regression showing a 1.12-fold increase in odds for each additional millimeter in node size. These findings demonstrate substantial anatomical variability and highlight the limitations of gross-only protocols, which underestimate nodal yield and risk missing small nodes. Our results support extended PLND as a more reliable staging approach than limited dissection and emphasize the value of total histological submission to ensure accurate pathological staging in prostate cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.